210 related articles for article (PubMed ID: 33816718)
1. Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery.
Liu Y; Côté MM; Cheney MC; Lindeman KG; Rushin CC; Hutter MM; Yu EW
Bone Rep; 2021 Jun; 14():100760. PubMed ID: 33816718
[TBL] [Abstract][Full Text] [Related]
2. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue.
Bredella MA; Greenblatt LB; Eajazi A; Torriani M; Yu EW
Bone; 2017 Feb; 95():85-90. PubMed ID: 27871812
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal 5-Year Evaluation of Bone Density and Microarchitecture After Roux-en-Y Gastric Bypass Surgery.
Lindeman KG; Greenblatt LB; Rourke C; Bouxsein ML; Finkelstein JS; Yu EW
J Clin Endocrinol Metab; 2018 Nov; 103(11):4104-4112. PubMed ID: 30219833
[TBL] [Abstract][Full Text] [Related]
4. Bone Density and Trabecular Morphology at Least 10 Years After Gastric Bypass and Gastric Banding.
Lindeman KG; Rushin CC; Cheney MC; Bouxsein ML; Hutter MM; Yu EW
J Bone Miner Res; 2020 Nov; 35(11):2132-2142. PubMed ID: 32663365
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study.
Carr A; Kerr SJ; Richardson R; Ebeling P; Pocock N; Rojas J; Martinez E; Hoy J;
J Bone Miner Res; 2019 Dec; 34(12):2192-2197. PubMed ID: 31361922
[TBL] [Abstract][Full Text] [Related]
6. The PYY/Y2R-deficient male mouse is not protected from bone loss due to Roux-en-Y gastric bypass.
Zahedi B; Daley EJ; Brooks DJ; Bruce M; Townsend RL; Berthoud HR; Bouxsein ML; Yu EW
Bone; 2023 Feb; 167():116608. PubMed ID: 36368466
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study.
Li M; Cheng Q; Huo YN; Chao AJ; He L; Xue QY; Xu J; Yan SG; Jin H; Zhang ZL; Lin JH; Jin XL; Xu YJ; Liu F; Xia WB
Arch Osteoporos; 2022 Jan; 17(1):14. PubMed ID: 35020038
[TBL] [Abstract][Full Text] [Related]
8. Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women.
Schafer AL; Kazakia GJ; Vittinghoff E; Stewart L; Rogers SJ; Kim TY; Carter JT; Posselt AM; Pasco C; Shoback DM; Black DM
J Bone Miner Res; 2018 Jun; 33(6):975-986. PubMed ID: 29281126
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
[TBL] [Abstract][Full Text] [Related]
10. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
Eastell R; Lang T; Boonen S; Cummings S; Delmas PD; Cauley JA; Horowitz Z; Kerzberg E; Bianchi G; Kendler D; Leung P; Man Z; Mesenbrink P; Eriksen EF; Black DM;
Osteoporos Int; 2010 Jul; 21(7):1277-85. PubMed ID: 19802508
[TBL] [Abstract][Full Text] [Related]
11. Exercise Mitigates Bone Loss in Women With Severe Obesity After Roux-en-Y Gastric Bypass: A Randomized Controlled Trial.
Murai IH; Roschel H; Dantas WS; Gil S; Merege-Filho C; de Cleva R; de Sá-Pinto AL; Lima F; Santo MA; Benatti FB; Kirwan JP; Pereira RM; Gualano B
J Clin Endocrinol Metab; 2019 Oct; 104(10):4639-4650. PubMed ID: 31322672
[TBL] [Abstract][Full Text] [Related]
12. Bone loss after bariatric surgery: discordant results between DXA and QCT bone density.
Yu EW; Bouxsein ML; Roy AE; Baldwin C; Cange A; Neer RM; Kaplan LM; Finkelstein JS
J Bone Miner Res; 2014 Mar; 29(3):542-50. PubMed ID: 23929784
[TBL] [Abstract][Full Text] [Related]
13. Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
Hadji P; Kauka A; Ziller M; Birkholz K; Baier M; Muth M; Bauer M
Osteoporos Int; 2014 Apr; 25(4):1369-78. PubMed ID: 24504100
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
Zhu K; Zhang J; Zhang C; Zhao Z; Gao J; Li X; Xia X; Xu X; Zhang T; Guan J
Osteoporos Int; 2021 Mar; 32(3):559-564. PubMed ID: 32989470
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic Acid for prevention of bone and muscle loss after BAriatric Surgery (ZABAS)-a study protocol for a randomized controlled trial.
Gam S; Gram B; Juhl CB; Hermann AP; Hansen SG
Trials; 2022 Oct; 23(1):861. PubMed ID: 36209245
[TBL] [Abstract][Full Text] [Related]
16. Effects of Gastric Bypass and Gastric Banding on Bone Remodeling in Obese Patients With Type 2 Diabetes.
Yu EW; Wewalka M; Ding SA; Simonson DC; Foster K; Holst JJ; Vernon A; Goldfine AB; Halperin F
J Clin Endocrinol Metab; 2016 Feb; 101(2):714-22. PubMed ID: 26600045
[TBL] [Abstract][Full Text] [Related]
17. Secondary Hyperparathyroidism, Bone Density, and Bone Turnover After Bariatric Surgery: Differences Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.
de Holanda NCP; Baad VMA; Bezerra LR; de Lima SKM; Filho JM; de Holanda Limeira CC; Cavalcante TCF; Montenegro ACP; Bandeira F
Obes Surg; 2021 Dec; 31(12):5367-5375. PubMed ID: 34635988
[TBL] [Abstract][Full Text] [Related]
18. Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
Koldkjær Sølling AS; Harsløf T; Langdahl B
Osteoporos Int; 2019 May; 30(5):995-1002. PubMed ID: 30656367
[TBL] [Abstract][Full Text] [Related]
19. Bone Mineral Density and Turnover After Sleeve Gastrectomy and Gastric Bypass: A Randomized Controlled Trial (Oseberg).
Hofsø D; Hillestad TOW; Halvorsen E; Fatima F; Johnson LK; Lindberg M; Svanevik M; Sandbu R; Hjelmesæth J
J Clin Endocrinol Metab; 2021 Jan; 106(2):501-511. PubMed ID: 33150385
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin levels and changes in bone metabolism after bariatric surgery.
Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
